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ABSTRACT  
Solid dispersion is a technique which is widely and successfully applied to improve the solubility, dissolution rates and consequently the 
bioavailability of poorly soluble drugs. Dispersion of one or more active ingredients (hydrophobic) is done with an i nert carrier (hydrophilic) at 
solid-state prepared by fusion method, solvent, and melting solvent method. In this review article, we have focused on the methods of 
preparation, advantages, disadvantages and characterization of the solid dispersions. 
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Solid dispersion is defined as a group of solid products 
which should contain at least two different components, like 
a hydrophilic matrix and a hydrophobic drug. Hydrophilic 
matrix can be crystalline or amorphous. The first drug 
whose rate and extent of absorption was significantly 
enhanced using solid dispersion was sulfathiazole in which 
eutectic mixture of sulfathiazole with urea as the inert 
carrier was formed. Lyophilization is a molecular mixing 
technique where the drug and carrier were co-dissolved in 
cyclohexanol, frozen and then sublimed under vacuum to 
obtain a lyophilized molecular dispersion [1]. 
Solubility is not to be confused with the ability to dissolve or 
liquefy a substance, since these processes may occur not 
only because of a chemical reaction. Solubility does not 
depend on particle size or other kinetic factors; given 
enough time, even large particles will eventually dissolve [2, 
3].  
Several factors such as complicated preparation method, low 
reproducibility of  physicochemical properties, difficulty of 
formulation development and scale-up and physical 
instability for solid dispersion make it difficult to apply the 
systems to solid dispersion dosage forms. Especially in order 
to maintain a supersaturation level of drug for an extended 
time, re-crystallization of drug must be prevented during its 
release from dosage form4.  
After administration of a drug orally, it firstly dissolves in 
gastric media and then permeates the membranes of GI tract 
to reach into the blood. Therefore, a drug with poor aqueous 
solubility will exhibit dissolution rate limited absorption.  
35-40% of newer drugs suffer from poor aqueous 
solubility5,6. 
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Figure 1. Approaches to Increase solubility/ Dissolution 
 
ADVANTAGES OF SOLID DISPERSION 
1. Improving drug bioavailability by changing water solubility which is possible only by solid dispersion7. 
2. Increase in dissolution rate & extent of absorption and reduction in Pre systemic metabolism. 
3. Transformation of liquid form to solid form. 
4. It is more efficient than particle size reduction technique [8]. 
DISADVANTAGES OF SOLID DISPERSION  
1. Major disadvantage is their instability. They show changes in crystallinity and a decrease in dissolution rate with ageing. 
2. Temperature and moisture have more deteriorating effect on solid dispersions than on physical mixtures. 
3. Difficulty in handling because of tackiness [9,10]. 
METHODS OF PREPARATION OF SOLID DISPERSIONS:  
 
Figure 2. Solid State Solid Dispersions 
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Figure 3. Methods of preparation of Solid Dispersion 
 
Various methods used for preparation of solid dispersion 
system. These methods are given below.  
1. Melting solvent method: This method is prepared 
by physical mixture of a drug and a water soluble carrier and 
heating it directly until it is melted. Final solid mass is 
crushed and sieved and then it passed with other 
modification procedures [11,12]. 
2. Solvent evaporation method: In this type of 
method dissolve the drug and polymeric carrier in a common 
solvent, such as ethanol, chloroform, mixture of ethanol and 
dichloromethane, resulting films are pulverized and milled 
[13-17], 
3. Hot melt extrusion method: In this method 
extruder is utilized for intense mixing of components. 
Physical mixture of both the drug and carrier is introduced 
into the hopper then passed through screw and finally it is 
extruded from the die [18]. 
4. Melt agglomeration Process: This technique has 
been used to prepare solid dispersion wherein the binder acts 
as a carrier. Solid dispersion are prepared by heating binder, 
drug & excipient to a temperature above the melting point of 
the binder or by spraying a dispersion of drug in molten binder 
on the heated excipient by using shear mixer [19-21]. 
5. Lyophilization: it is a phenomenon of transfer of 
heat and mass from and to the product. It’s an alternative 
method to solvent evaporation in which molecular mixture 
technique is used[22]. 
EVALUATION PARAMETERS OF SOLID DISPERSION: 
Various methods to evaluate the solid dispersion are as follows: 
Drug -carrier miscibility 
• Hot stage microscopy 
• Differential scanning calorimetry – Helps to determine that 
the treated drug melting is similar to the original form of the 
drug. 
• Powder X-ray diffraction – The intensity peaks shows the 
crystal lattice of the treated drug. Low and high intensity peaks 
are evaluated for the crystallization index. 
• Spectroscopic methods like Raman spectroscopy, FT-IR 
spectroscopy – the functional groups of the treated drug 
produces similar peaks as that of the original drug form which 
helps to determine that the no changes in the functional 
structure of the drug moiety22. 
Physical Structure 
• Scanning electron microscopy – SEM shows the surface 
morphology of the drug particles and to evaluate them with the 
treated drug23. 
• Surface area analysis – The surface area is directly 
proportional to the solubility of the drug.  
• Dynamic vapour sorption 
• Inverse gas chromatograph 
• Atomic force microscopy 
  • Raman microscopy 
  Amorphous content 
  • Polarised light optical microscopy 
  • Hot stage microscopy 
  • Humidity stage microscopy 
  • DSC (MTDSC) 
  • Powder X-ray diffraction24 
Stability 
  • Humidity studies     
  • Isothermal Calorimetry 
  • DSC (TG, Temperature recrystallization) 
  • Saturated solubility studies 
Dissolution enhancement 
 • Dissolution 
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 • Intrinsic dissolution 
 • Dynamic solubility 
 • Dissolution in bio-relevant media25 
Applications of solid Dispersion: 
The solid dispersion technique may have numerous 
pharmaceutical applications, which are: 
1. To stabilize unstable drugs and protect against 
decomposition by processes such as hydrolysis, 
oxidation, racemization, photo oxidation etc26. 
2. To reduce side effects of certain drugs:- A third factor 
that affects the rate of dissolving is the size of 
solute particles. For a given amount of solute, 
smaller particles have greater surface area. With 
greater surface area, there can be more contact 
between particles of solute and solvent27. 
3. Masking of unpleasant taste and smell of drugs:- Taste 
masking has always been the integral part of 
formulation especially for pediatric formulations. 
During almost last three decades advanced novel 
formulation techniques have been utilized to improve 
the aesthetics of the final products.  
4. To avoid undesirable incompatibility. 
5. To obtain a homogeneous distribution of a small 
amount of drug in solid state :- Solubility is the 
property of a solid, liquid, or gaseous chemical 
substance called solute to dissolve in a solid, liquid, or 
gaseous solvent to form a homogeneous solution of the 
solute in the solvent. The solubility of a substance 
fundamentally depends on the solvent used as well as 
on temperature and pressure. 
6. To dispense liquid or gaseous compounds28. 
7. To formulate a fast release priming dose in a sustained 
release dosage form.  
8.  To formulate sustained release preparation of soluble 
drugs by dispersing the drug in poorly soluble or 
insolub to formulate sustained release preparation of 
soluble drugs by dispersing the drug in poorly soluble 
or insoluble carrier29.  
9. To enhance the absorption of drug. 
10. To reduce side effects:- 
 (A). The binding ability of drugs for example to the 
erythrocyte membrane is decreased by making its 
inclusion complex. 
 (B). The damage to the stomach mucous membranes by 
certain non-steroidal anti-inflammatory drugs can be 
reduced by administration as an inclusion compound30. 
Challenging future for Solid Dispersion Technique: 
A. Inability to scale bench top formulations to 
manufacturing sized batches, 
B. Difficulty to control physiochemical properties , 
C. Difficulty in delivering solid dispersion formulations as 
tablet or capsule dosage forms and  
D. Physical and chemical instability of the drug and/or the 
formulation [31]. 
Commercial Solid Dispersion Products: 





Increasing the Bioavailability of a poorly soluble drug is a 
challenging aspect of drug development.on the basis of back 
literature we have concluding solid dispersion is the 
promisable technique increment of solubility and 
bioavailability of water insoluble (BCS Class II). Because of 
the poor aqueous solubility the drug possesses dissolution 
problems due to which the in vivo absorption of the drug is 
reduced and thus the bioavailability is reduced, making the 
drug inappropriate for oral consumption and therefore 
solubility enhancement become necessary for such drug 
candidate. Solid dispersion is a most simple and efficient 
technique for increasing the aqueous solubility of a drug. 
Solid dispersion systems have been realized as extremely 
useful tool in improving the dissolution properties of poorly 
water-soluble drugs based on the observed entrapment 
rates and pesticide loadings, the processes for preparing the 
solid dispersions were optimized. 
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